Carnegie Capital Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Carnegie Capital Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$0.73 - $3.74 $22,132 - $113,389	30,318 New	30,318 $95,000
Q2 2022 Jul 13, 2022	SELL	$2.2 - $4.2 $332,701 - $635,157	-151,228 Closed	0 $0
Q1 2022 Apr 11, 2022	SELL	$2.83 - $8.69 $32,912 - $101,064	-11,630 Reduced 7.14%	151,228 $609,000
Q4 2021 Jan 21, 2022	BUY	$8.31 - $14.92 $265,089 - $475,948	31,900 Added 24.36%	162,858 $1.35 Million
Q3 2021 Oct 08, 2021	BUY	$9.15 - $13.28 $1.2 Million - $1.74 Million	130,958 New	130,958 $1.52 Million

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.